Rossari Biotech reported second-quarter results that topped market expectations, driven by 34% growth in exports and a recovery in its consumer business. The specialty chemicals company is now prioritizing the sale of non-core assets to become debt-free by early 2028. While operational efficiency is improving, investors may monitor how the company manages raw material costs and its ongoing expansion projects.
Rossari Biotech reported financial results for the second quarter of the 2026-27 fiscal year that came in above brokerage expectations. The company benefited from consistent volume growth in its core business-to-business (B2B) divisions, which include home care, personal care, performance chemicals, and textile chemicals.
A key highlight in the recent performance was the strong demand in the export market, which grew by 34% compared to the same period last year. Additionally, the company’s business-to-consumer (B2C) segment reached a breakeven point during the quarter, signaling that this unit has moved past the operational loss stage.
Management has initiated a strategic plan to simplify the business structure and improve its financial health. The company is actively working to sell off non-core assets, with the specific goal of clearing its debt burden to become a debt-free company by the first half of the 2028 fiscal year. This shift is designed to focus capital allocation toward high-growth areas and improve the company's return on investment.
Specialty chemical manufacturers often face volatility in input costs. Rossari Biotech’s ability to maintain profit margins is closely linked to the steady availability and stable pricing of ethylene oxide, a vital raw material in its production process. Changes in global supply or pricing for this material can directly affect the company's manufacturing costs and operational margins.
The brokerage house Nirmal Bang recently adjusted its target price for the stock to Rs 680, based on valuations projected for September 2028. The analysts pointed to the expected completion of planned capital spending projects and better clarity on raw material supply as factors that could influence the company’s stock performance in the coming years. They projected that the company could see steady growth in revenue and profit through fiscal year 2029.
Looking ahead, the primary focus for the company will be the successful execution of its asset divestment plan to reduce debt. Shareholders may also track whether the company can sustain the volume growth seen in its B2B and export segments, as these remain the main drivers of its current financial performance. Monitoring upcoming quarterly updates on debt levels and raw material price trends will provide more clarity on the company's progress toward its financial goals.